About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Seattle | 547 Studies

Clinical Trials Breast CancerSeattle

Breast Cancer Clinical Trials in Seattle

Find 547 clinical trials for breast cancer near Seattle, Washington. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 547 trials

Active not recruitingNiraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerThis phase IB trial evaluates the effect of niraparib and TSR-042 in treating patients with BRCA-mutated breast, pancreas, ovary, fallopian tube, or primary peritoneal cancer that…NCT04673448·Seattle, Washington CompletedEfficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)The purpose of this study is to determine the safety and efficacy of combination therapy with pembrolizumab (MK-3475) and lenvatinib (E7080/MK-7902) in participants with triple…NCT03797326·Duarte, California and 87 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

No longer availableExpanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast CancerThis is an expanded access protocol to allow continued maintenance therapy with ABT-888 (veliparib) for three patients with metastatic triple negative breast cancer who are…NCT02985658·Seattle, Washington

TerminatedA Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast CancerThe goal of this clinical trial is to evaluate CLBR001 and ABBV-461 as a treatment for patients with locally advanced or metastatic breast cancer.NCT06878248·Augusta, Georgia and 4 others

CompletedTestosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentThis randomized phase III trial studies testosterone to see how well it works compared to placebo in treating postmenopausal patients with arthralgia (joint pain) caused by…NCT01573442·Anchorage, Alaska and 528 others

CompletedIntraoperative Radiation Therapy in Early Stage Breast CancerSingle arm study to assess the effectiveness of single dose intraoperative radiation therapy in patient with in situ and early stage breast cancer.NCT02266602·Seattle, Washington

CompletedDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing.NCT01547741·Anchorage, Alaska and 914 others

CompletedDigital Mammography Screening Trial (ACRIN6652)RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for cancer.NCT00008346·Los Angeles, California and 31 others

CompletedS9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast CancerRATIONALE: Drugs used in chemotherapy for breast cancer may damage the genes of cells. This may lead to the development of secondary cancers.NCT00003095·Mobile, Alabama and 82 others

CompletedEribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast CancerThis phase II trial studies how well eribulin mesylate works in treating patients with previously treated breast cancer that has spread to other places in the body.NCT01908101·Anchorage, Alaska and 11 others

CompletedA Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast CancerThis study is to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast cancer (MBC).NCT04699630·Birmingham, Alabama and 10 others

CompletedMRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast CancerRATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for breast cancer.NCT00003736·San Francisco, California and 11 others

CompletedEffect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal WomenRATIONALE: A low-calorie diet and/or exercise program may help lower an overweight or obese postmenopausal woman's risk of developing breast cancer.NCT00470119·Seattle, Washington

CompletedA Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast CancerThis multicenter, randomized, single-blind, placebo-controlled, two arm study will evaluate the efficacy and safety of paclitaxel with GDC-0941 versus paclitaxel with placebo in…NCT01740336·Sedona, Arizona and 96 others

TerminatedDose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast CancerThis is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with HR+/HER2- advanced or metastatic breast…NCT02964507·Birmingham, Alabama and 37 others

CompletedS0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast CancerRATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, doxorubicin, and cyclophosphamide, work in different ways to stop the growth…NCT00856492·Mobile, Alabama and 365 others

CompletedCombination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph NodesRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003782·Huntsville, Alabama and 156 others

CompletedA Study of PDR001 in Combination With LCL161, Everolimus or PanobinostatThe purpose of this study was to combine the PDR001 checkpoint inhibitor with several agents with immunomodulatory activity to identify the doses and schedule for combination…NCT02890069·Santa Monica, California and 24 others

Active not recruitingTesting Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast CancerThis Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive…NCT05705401·Phoenix, Arizona and 417 others

CompletedOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantRATIONALE: Ondansetron may help lessen or prevent nausea and vomiting in patients undergoing stem cell transplant.NCT00795769·Seattle, Washington

PreviousPage 11 of 28Next

Other Conditions in Seattle

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma